Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)

Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)

Bibliographic Details
Main Authors:	Jiaxin Hong, Yao-An Shen, Chih-Yi Hsu, Peng Huang, Alicja Tomaszewski, Edward Gabrielson, Ie-Ming Shih, Stephanie Gaillard, Tian-Li Wang
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2022-11-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304222000502

Similar Items

Platinum chemotherapy for early triple-negative breast cancer
by: Sofia RE. Mason, et al.
Published: (2024-06-01)

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC).
by: Shipra Gandhi, et al.
Published: (2021-03-01)

Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple negative breast cancer (TNBC)
by: P. Krivorotko, et al.
Published: (2021-04-01)

Efficacy and safety of Anlotinib based neoadjuvant chemotherapy for locally advanced triple negative breast cancer (TNBC)
by: Kuojun Ren, et al.
Published: (2024-10-01)

Defining triple‐negative breast cancer with neuroendocrine differentiation (TNBC‐NED)
by: Sean M Hacking, et al.
Published: (2023-07-01)

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
by: Radhakrishnan Vishnubalaji, et al.
Published: (2021-07-01)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
by: Hoon Sik Choi, et al.
Published: (2021-08-01)

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022-04-01)

Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer
by: Yimeng Chen, et al.
Published: (2023-02-01)

Antiproliferative effect of Saraca asoca methanol bark extract on triple negative breast cancer (TNBC)
by: Chennattu M. Pareeth, et al.
Published: (2024-03-01)

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
by: Lijuan Weng, et al.
Published: (2024-03-01)

P114 Characteristics of residual tumor after neoadjuvant chemotherapy (nact)may predict outcomes in patients with triple negative breast cancer (tnbc)
by: M. Frolova, et al.
Published: (2023-03-01)

Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)
by: Iris Y. Sheng, et al.
Published: (2019-01-01)

Pengaruh pemberian Iodine-131 terhadap viabilitas cell line Triple Negative Breast Cancer (TNBC)
by: Katrin Monika, et al.
Published: (2023-11-01)

Predicting Relapse in Patients With Triple Negative Breast Cancer (TNBC) Using a Deep-Learning Approach
by: Guangyuan Yu, et al.
Published: (2020-09-01)

Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines
by: Paola Maria Bonaccorsi, et al.
Published: (2019-10-01)

Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
by: Jung Ok Lee, et al.
Published: (2019-10-01)

Pathological Complete Response with Platinum Containing Neoadjuvant Chemotherapy in Triple-negative Breast Cancer: An Interventional Study
by: Binila Mary Jose, et al.
Published: (2024-04-01)

Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
by: Zhen-Yu Li, et al.
Published: (2020-10-01)

A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)
by: Adhip Arora, et al.
Published: (2025-02-01)

Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).
by: John Hilton, et al.
Published: (2018-01-01)

1212 Bioengineered tumour-targeted interleukin-12 selectively cures murine triple-negative breast cancer (TNBC)
by: Anguraj Sadanandam, et al.
Published: (2023-11-01)

982 Immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC)
by: Geoffrey I Shapiro, et al.
Published: (2023-11-01)

Efficacy and safety of neoadjuvant therapy for Triple-Negative Breast Cancer (TNBC): a Bayesian network meta-analysis
by: Y. Yu, et al.
Published: (2021-04-01)

Prognostic and Predictive Markers for Early Stage Triple‐Negative Breast Cancer Treated With Platinum‐Based Neoadjuvant Chemotherapy
by: Zhenhui Zhao, et al.
Published: (2024-10-01)

Outcome of Triple Negative Breast Cancer(TNBC) as compared to other breast cancers in Bir Hospital, National Academy of Medical Sciences
by: Anip Joshi, et al.
Published: (2024-11-01)

The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database
by: Kaiyan Huang, et al.
Published: (2022-04-01)

In vitro anticancer efficacy of a polyphenolic combination of Quercetin, Curcumin, and Berberine in triple negative breast cancer (TNBC) cells
by: Akanksha Kashyap, et al.
Published: (2022-05-01)

614 Investigating immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC)
by: Elizabeth Mittendorf, et al.
Published: (2021-11-01)

The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)
by: Jane Howard, et al.
Published: (2022-01-01)

Current status and novel directions in triple negative breast cancer patients. Risk factors. Role of the platinum-based chemotherapy
by: Olivia IONESCU, et al.
Published: (2016-06-01)

The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
by: Olga Caramelo, et al.
Published: (2019-03-01)

Platinum-Based Chemotherapy and Immunotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis and Indirect Treatment Comparison
by: Qin He, et al.
Published: (2021-07-01)

Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis
by: Canling Lin, et al.
Published: (2022-10-01)

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
by: Dandan Yi, et al.
Published: (2019-01-01)

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
by: Teresa Rossi, et al.
Published: (2023-01-01)

Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC)
by: Yuping Liu, et al.
Published: (2018-11-01)

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
by: Foluso O. Ademuyiwa, et al.
Published: (2022-12-01)

Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
by: Aushia Tanzih Al Haq, et al.
Published: (2022-01-01)

P118 Efficacy of platinum-based neoadjuvant chemotherapy in early triple-negative breast cancer according to germline BRCA mutation
by: S.J. Bae, et al.
Published: (2023-03-01)